Export file:

Format

  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text

Content

  • Citation Only
  • Citation and Abstract

The incidence of pulmonary tuberculosis in patients with anthracosis

1 Department of Internal Medicine, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
2 Student Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran
3 Zoonoses Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran

Special Issues: Innovations in Immunology

Background: Anthraco-fibrosis is a potential risk factor for tuberculosis (TB). The aim of this study was to compare the incidence of pulmonary TB in patients with anthracosis and patients without anthracosis. Methods: In this study, all patients who were admitted to the study were selected through enumeration method between 2017 and 2018. Patients with radiological evidence of TB has been considered as suspected of pulmonary TB, and bronchoscopy has been used to detect anthracosis. 40 patients were enrolled as anthracosis patients and 138 as non-anthracosis group. The final diagnosis of active tuberculosis was performed by PCR assay using bronchoalveolar lavage. The data were analyzed by SPSS V.22 using chi-square and logistic regression tests. Results: The incidence of active TB in women and men was 19.3% and 2.1%, respectively (p < 0.001) and the incidence of anthracosis was 28.9% and 16.8% respectively (p = 0.05) which both had a significant difference and were higher in women. Of all patients with anthracosis, 22.5% had active TB. The findings showed that exposure to smoke and anthracosis increases the risk of TB significantly (p < 0.001). Conclusion: The results of this study showed that the patients with anthracosis and those who had long-term exposure to smoke are needed to be evaluated in case of active tuberculosis.
  Figure/Table
  Supplementary
  Article Metrics

References

1. Kasper DL, Fauci AS, Hauser SL, et al. (2018) Harrison's Principles of Internal Medicine, (Vol. 1 & Vol. 2), McGraw Hill Professional.

2. Pazoki M, Goodarzi HM, Taheri AH, et al. (2012) Prevalence of tuberculosis in patients with anthracosis: Study on 150 subjects. Arch Iran Med 15: 128.

3. Bialvaei AZ, Asgharzadeh M, Aghazadeh M, et al. (2017) Challenges of tuberculosis in Iran. Jundishapur J Microbiol 10.

4. Qorbani M, Yunesian M, Baradaran HR (2014) Indoor smoke exposure and risk of anthracosis. Iran J Med Sci 39: 571.

5. DEMİRCİ NY, Alici IO, Yilmaz A, et al. (2015) Risk factors and maximum standardized uptake values within lymph nodes of anthracosis diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Turk J Med Sci 45: 984–990.    

6. Mirsadraee M (2014) Anthracosis of the lungs: etiology, clinical manifestations and diagnosis: a review. Tanaffos 13: 1.

7. Uçar EY, Araz Ö, Akgün M, et al. (2014) Bronchial Anthracosis-Anthracofibrosis: Potential Causes and Clinical Characteristics. Eurasian J Pulmonol 16: 17–20.    

8. Kunal S, Shah A (2017) The concomitant occurrence of pulmonary tuberculosis with bronchial anthracofibrosis. Indian J Tuber 64: 5–9.    

9. Rezaeetalab F (2016) Endobronchial tuberculosis in anthracotic bronchitis. Cough 89: 0–01.

10. Kim HJ, Kim SD, Shin DW, et al. (2013) Relationship between bronchial anthracofibrosis and endobronchial tuberculosis. Korean J Intern Med 28: 330.    

11. Gupta A, Shah A (2011) Bronchial anthracofibrosis: an emerging pulmonary disease due to biomass fuel exposure. Int J Tuberc Lung Dis 15: 602–612.    

12. Pilaniya V, Kunal S, Shah A (2017) Occurrence of bronchial anthracofibrosis in respiratory symptomatics with exposure to biomass fuel smoke. Adv Respir Med 85: 127–135.

13. Heidarnazhad H (2012) Anthracosis in Iran, un-answered questions. Arch Iran Med 15: 124.

14. Kahkouee S, Pourghorban R, Bitarafan M, (2015) Imaging findings of isolated bronchial anthracofibrosis: A computed tomography analysis of patients with bronchoscopic and histologic confirmation. Arch de Bronconeumología 51: 322–327.

15. Fekri MS, Lashkarizadeh MR, Kardoost AH, et al. (2010) Bronchial anthracosis and pulmonary tuberculosis. Tanaffos 9: 21–25.

16. Ghanei M, Aslani J, Peyman M, et al. (2011) Bronchial anthracosis: a potent clue for diagnosis of pulmonary tuberculosis. Oman Med J 26: 19.    

17. Mireles-Cabodevila E, Karnak D, Shah SS, et al. (2006) Anthracostenosis. J Bronchology Interventional Pulmonol 13: 153–155.

18.Kim HY, Im JG, Goo JM, et al. (2000) Bronchial anthracofibrosis (inflammatory bronchial stenosis with anthracotic pigmentation): CT findings. AJR Am J Roentgenol 174: 523–527.    

19.Razi E, Akbari H, Nematollahi L. (2007) Study of Mycobacteria and Mycobacterium Frequency in Patients with Bronchial Anthracofibrosis. J Med Council Iran 26: 346–352.

20.Törün T, Güngör G, Özmen I, et al. (2007) Bronchial anthracostenosis in patients exposed to biomass smoke. Turkish Res J 8: 48–51.

21.Dennis RJ, Maldonado D, Norman S, et al. (1996) Woodsmoke exposure and risk for obstructive airways disease among women. Chest 109: 115–119.    

22.Sandoval J, Salas J, Martinez-Guerra ML, et al. (1993) Pulmonary arterial hypertension and cor pulmonale associated with chronic domestic woodsmoke inhalation. Chest 103: 12–20.    

23.Park HJ, Park SH, Im SA, et al. (2008) CT differentiation of anthracofibrosis from endobronchial tuberculosis. AJR Am J Roentgenol 191: 247–251.    

© 2019 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Article outline

Show full outline
Copyright © AIMS Press All Rights Reserved